Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC LQZ-7I | 195822-23-2 | 99.8% | 348.35 | 100 MG
SDP

Catalog No. 5000351906
Encompass_Preferred

LQZ-7I is a survivin-targeting inhibitor that inhibits survivin dimerization. It orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.

  • Inhibits survivin dimerization
  • Effectively inhibits xenograft tumor growth
  • Induces survivin loss in tumors
  • Improved cytotoxicity against C4-2 and PC-3 cells
  • Selectively reduces survivin expression
  • Suppresses tumor growth in animal models without adverse effects

Catalog No. 50-003-51906 Supplier Medchemexpress LLC Supplier No. HY136538100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

LQZ-7I is a survivin-targeting inhibitor that inhibits survivin dimerization. It orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.

  • Inhibits survivin dimerization
  • Effectively inhibits xenograft tumor growth
  • Induces survivin loss in tumors
  • Improved cytotoxicity against C4-2 and PC-3 cells
  • Selectively reduces survivin expression
  • Suppresses tumor growth in animal models without adverse effects

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.